Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone 
The four types of dementia most people don’t know exist 
Obayashi to Acquire Multiplex in $526M Expansion Deal 
SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples 
US Stock Futures Edge Higher Ahead of Key Federal Reserve Decision 
Why financial hardship is more likely if you’re disabled or sick 
The ghost of Robodebt – Federal Court rules billions of dollars in welfare debts must be recalculated 
RFK Jr. Spokesman Resigns Over Trump Administration’s Flavored E-Cigarette Policy 
Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race 
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 
Asian Currencies Steady as Dollar Holds Firm Ahead of Fed Decision and US-Iran Deal Details 
Japan Signals Readiness to Intervene as USD/JPY Nears 161 Amid Yen Weakness 
Asian Stocks Advance as Nikkei Nears Record High Ahead of Fed Decision 
Why have so few atrocities ever been recognised as genocide? 
Australia’s Atlas Arteria Rejects IFM Global’s Increased A$7.4 Billion Takeover Offer 
6 simple questions to tell if a ‘finfluencer’ is more flash than cash 
Is dark chocolate healthier than milk chocolate? 2 dietitians explain 
Bubs Australia will manufacture and distribute Bubs’ Chinese-label goat milk infant formula in China according to new Chinese standards. under an agreement with Heilongjiang Ubeite Dairy Group (HUG).
The new standards will come into effect in February 2023 .
The “ultra-premium” infant formula has been specially developed for Chinese infants using easily-digestible A2 goat-milk protein, sn2 palmitate (OPO), lactoferrin prebiotics, and nucleotides.
HUG has started submission with the State Administration for Market Regulation (SAMR) to renew its registration in line with China’s new GB standards for exclusive use under the Bubs brand.
According to Kristy Carr, Bubs founder and CEO, they have built strong brand trust and loyalty with Chinese families through marketing and selling Bubs English label infant formula products via the crossborder eCommerce channel, which accounts for around 20 percent of total Chinese infant formula sales.
If approved by SAMR, the formula will give Bubs access to the remaining 80 percent of China’s $25.9 billion infant formula market.
Bubs will also enter into a joint venture agreement, where it will hold a 75 percent interest, with Zhitong Health Technology to distribute its Chinese label goat infant formula products.
Bubs Australia expects to launch its product in the second half of FY23, subject to receiving SAMR approval.
